Inotuzumab ozogamicin then blinatumomab for older adults with newly diagnosed, ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Extended follow-up of alliance for clinical trials in oncology A041703 cohort 1 reveals durable remission and survival

Matthew J. Wieduwilt, Richard M. Stone, Oudom Kour et al.|Blood|2025

Cited by 2